Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
30
Jun |
BioElectronics Receives New OTC Product ApprovalsCategory: Pain / Anesthetics | Leave a Comment |
BioElectronics Corporation (PINKSHEETS: BIEL), developers of innovative pain-relieving medical devices, announced that its Allay™ Menstrual Pain Therapy product has been approved for over the counter sale by Health Canada for the treatment of menstrual pain symptoms, including cramps and abdominal pain, and for reducing the use of pain medication associated with menstruat…
|
30
Jun |
Scientists Win Four R&D 100 Awards For Environment, Biology, Security TechnologiesCategory: Medical Devices / Diagnostics | Leave a Comment |
Technologies that enhance threat and radiation detection, improve life sciences research and reduce our dependence on fossil fuels have received recognition for their innovation. R&D Magazine honored four advancements developed by researchers at the Department of Energy’s Pacific Northwest National Laboratory with its annual R&D 100 awards…
|
30
Jun |
New Research Project To Develop Reliable And Cost-effective Virtual AutopsiesCategory: IT / Internet / E-mail | Leave a Comment |
A new research project at the University of Leicester is set to play a vital role in continuing research into viable alternatives to invasive autopsies, which many families find to be unpleasant…
|
29
Jun |
Effects of Medical Therapies on Retinopathy Progression in Type 2 DiabetesCategory: Medic | Leave a Comment |
Background We investigated whether intensive glycemic control, combination therapy for dyslipidemia, and intensive blood-pressure control would limit the progression of diabetic retinopathy in persons with type 2 diabetes. Previous data …
|
29
Jun |
Effects of Medical Therapies on Retinopathy Progression in Type 2 DiabetesCategory: Medic | Leave a Comment |
Background We investigated whether intensive glycemic control, combination therapy for dyslipidemia, and intensive blood-pressure control would limit the progression of diabetic retinopathy in persons with type 2 diabetes. Previous data …
|
29
Jun |
Better Glucose Control Achieved With Medtronic’s Sensor-Augmented Insulin Pump Therapy Than Daily Insulin Injections For In Patients With DiabetesCategory: Diabetes | Leave a Comment |
Adults and children with diabetes who used the Medtronic MiniMed Paradigm® REAL-Time System achieved better glucose control without hypoglycemia increase compared to patients using multiple daily insulin injections, in the longest and largest randomized, controlled study of sensor-augmented insulin pump therapy in type 1 diabetes…
|
29
Jun |
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 DiabetesCategory: Medic | Leave a Comment |
Background Recently developed technologies for the treatment of type 1 diabetes mellitus include a variety of pumps and pumps with glucose sensors.
Methods In this 1-year, multicenter, randomized, controlled trial, …
|
29
Jun |
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 DiabetesCategory: Medic | Leave a Comment |
Background Recently developed technologies for the treatment of type 1 diabetes mellitus include a variety of pumps and pumps with glucose sensors.
Methods In this 1-year, multicenter, randomized, controlled trial, …
|
29
Jun |
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 DiabetesCategory: Medic | Leave a Comment |
Background Recently developed technologies for the treatment of type 1 diabetes mellitus include a variety of pumps and pumps with glucose sensors.
Methods In this 1-year, multicenter, randomized, controlled trial, …
|
29
Jun |
Continuous Glucose Monitoring — Coming of AgeCategory: Medic | Leave a Comment |
(No abstract is available for this citation)